Biopharma
Understanding the biopharma industry landscape
Biopharma is a dynamic segment of the life sciences industry focused on therapies derived from biological sources, including proteins, cells and genetic material. The sector encompasses biologics and biosimilars, cell and gene therapies, small molecules, biotechnology, contract research and manufacturing organizations (CROs and CMOs), and digital health innovators.
Across these subsegments, organizations are advancing scientific innovation while navigating research and development intensity, funding constraints, evolving regulatory and data requirements, and increasing manufacturing and supply chain complexity. From preclinical development to commercialization, success requires balancing growth opportunities with development costs, reimbursement and market access pressures, talent shortages, intellectual property considerations and regulatory demands.
At the same time, digital transformation, artificial intelligence-enabled analytics and advanced manufacturing technologies are reshaping how biopharma companies operate, scale and compete.
RSM provides integrated assurance, tax and consulting services tailored to biopharma companies, helping organizations manage risk, adapt to change and build resilient, scalable operating models throughout the lifecycle.
Helping biopharma's scale at the speed of change
Preclinical
Scale your people and infrastructure as you enter your clinical trials.
Clinical
Manage your cash flow as you work through the trial phase.
Precommercial
Formalize a commercial launch plan and team.
Commercial
Effectively manage your gross margin, market access and supply.
Biopharma industry trends
Biopharma organizations are navigating a set of interconnected trends that are redefining commercialization, capital strategy, innovation models and long‑term growth.
Commercialization and market access
Biopharma companies must align launch strategies with reimbursement, payer expectations and provider requirements to accelerate patient access and sustain commercial performance.
Accessing capital markets
Capital access is increasingly diversified, requiring biopharma companies to navigate a broader mix of traditional, alternative and global funding sources to support growth.
Human capital evolution
Biopharma organizations are rethinking talent models by combining specialized talent with AI, automation and outsourcing to drive speed, flexibility and innovation.
Business and technology transformation
Digital platforms, analytics and artificial intelligence are reshaping drug discovery and development, enabling faster insights, more targeted therapies and improved patient outcomes.
Licensing and M&A strategy
Licensing and mergers and acquisitions continue to fuel innovation, with emerging companies advancing early-stage science and established players selectively acquiring or licensing later‑stage assets.
Evolving drug development models
Drug development is becoming more flexible and partnership‑driven as companies balance speed, risk, cost and regulatory complexity in a changing global environment.
Government and regulatory changes
Regulatory, reimbursement and policy shifts are influencing how biopharma companies design trials, secure approvals, price therapies and plan market entry.
Biopharma industry services and solutions
RSM takes a middle market-first approach, delivering a right‑sized, integrated model designed to support biopharma companies at every stage of the lifecycle. With technology enablement as a core strength, we help organizations move with speed and focus, aligning strategy, execution and governance to create practical, scalable solutions.
Our biopharma services are built to deliver value quickly, helping companies manage complexity, pursue growth and adapt as priorities shift.
We provide key tax and assurance services as well as the following consulting services for biopharma companies:
Guides biopharma companies through commercialization readiness by aligning strategy, finance, operations, compliance and technology for a successful product launch.
Helps biopharma organizations manage pricing, contracts and gross‑to‑net processes to improve revenue accuracy, compliance and forecasting.
Delivers scalable, outsourced finance and accounting services tailored to the operational and regulatory needs of life sciences companies.
Supports biopharma companies through mergers, acquisitions and capital events with financial, accounting and transaction advisory services.
Helps biopharma organizations identify, assess and manage operational, regulatory, cybersecurity and compliance risks throughout the product lifecycle.
Frequently asked questions (FAQs)
Biopharma leaders often face similar questions as they navigate growth, commercialization and scale. The FAQs below address common issues we see across the biopharma lifecycle.